Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 30

1.

DNA bacteriophage as controls for clinical viral testing.

Walkerpeach CR, Pasloske BL.

Clin Chem. 2004 Nov;50(11):1970-1. No abstract available.

2.

Ribonuclease-resistant RNA controls and standards.

Brown D, Pasloske BL.

Methods Enzymol. 2001;341:648-54. No abstract available.

PMID:
11582811
3.

Ribonuclease inhibitors.

Pasloske BL.

Methods Mol Biol. 2001;160:105-11. Review. No abstract available.

PMID:
11265277
4.
5.

Armored RNA technology for production of ribonuclease-resistant viral RNA controls and standards.

Pasloske BL, Walkerpeach CR, Obermoeller RD, Winkler M, DuBois DB.

J Clin Microbiol. 1998 Dec;36(12):3590-4.

6.
7.
8.

Cloning the P. falciparum gene encoding PfEMP1, a malarial variant antigen and adherence receptor on the surface of parasitized human erythrocytes.

Baruch DI, Pasloske BL, Singh HB, Bi X, Ma XC, Feldman M, Taraschi TF, Howard RJ.

Cell. 1995 Jul 14;82(1):77-87.

9.

pTRIPLEscript: a novel cloning vector for generating in vitro transcripts from tandem promoters for SP6, T7 and T3 RNA polymerase.

Meador JW 3rd, McElroy HE, Pasloske BL, Milburn SC, Winkler MM.

Biotechniques. 1995 Jan;18(1):152-7,.

PMID:
7702842
10.

PfEMP3 and HRP1: co-expressed genes localized to chromosome 2 of Plasmodium falciparum.

Pasloske BL, Baruch DI, Ma C, Taraschi TF, Gormley JA, Howard RJ.

Gene. 1994 Jun 24;144(1):131-6.

PMID:
8026748
11.

Malaria, the red cell, and the endothelium.

Pasloske BL, Howard RJ.

Annu Rev Med. 1994;45:283-95. Review.

PMID:
8198384
12.

The promise of asexual malaria vaccine development.

Pasloske BL, Howard RJ.

Am J Trop Med Hyg. 1994;50(4 Suppl):3-10. Review.

PMID:
8172329
13.

Immunochemical characterization and differentiation of two approximately 300-kD erythrocyte membrane-associated proteins of Plasmodium falciparum, PfEMP1 and PfEMP3.

Van Schravendijk MR, Pasloske BL, Baruch DI, Handunnetti SM, Howard RJ.

Am J Trop Med Hyg. 1993 Nov;49(5):552-65.

PMID:
8250095
14.

Target antigens for asexual malaria vaccine development.

Howard RJ, Pasloske BL.

Parasitol Today. 1993 Oct;9(10):369-72. No abstract available.

PMID:
15463671
15.

Cloning and characterization of a Plasmodium falciparum gene encoding a novel high-molecular weight host membrane-associated protein, PfEMP3.

Pasloske BL, Baruch DI, van Schravendijk MR, Handunnetti SM, Aikawa M, Fujioka H, Taraschi TF, Gormley JA, Howard RJ.

Mol Biochem Parasitol. 1993 May;59(1):59-72.

PMID:
8515784
16.
17.

An improved microassay for Plasmodium falciparum cytoadherence using stable transformants of Chinese hamster ovary cells expressing CD36 or intercellular adhesion molecule-1.

Hasler T, Albrecht GR, Van Schravendijk MR, Aguiar JC, Morehead KE, Pasloske BL, Ma C, Barnwell JW, Greenwood B, Howard RJ.

Am J Trop Med Hyg. 1993 Mar;48(3):332-47.

PMID:
7682381
18.

The characterization of two monoclonal antibodies which react with high molecular weight antigens of asexual Plasmodium falciparum.

Handunnetti SM, Pasloske BL, van Schravendijk MR, Aguiar JC, Taraschi TF, Gormley JA, Howard RJ.

Mol Biochem Parasitol. 1992 Sep;54(2):231-46.

PMID:
1435861
19.

The role of polar pili in the adherence of Pseudomonas aeruginosa to injured canine tracheal cells: a semiquantitative morphologic study.

Zoutman DE, Hulbert WC, Pasloske BL, Joffe AM, Volpel K, Trebilcock MK, Paranchych W.

Scanning Microsc. 1991 Mar;5(1):109-24; discussion 124-6.

PMID:
1675811
20.

Surface molecules on Plasmodium falciparum-infected erythrocytes involved in adherence.

Howard RJ, Handunnetti SM, Hasler T, Gilladoga A, de Aguiar JC, Pasloske BL, Morehead K, Albrecht GR, van Schravendijk MR.

Am J Trop Med Hyg. 1990 Aug;43(2 Pt 2):15-29. Review.

PMID:
2202225
21.

Pseudomonas aeruginosa pili as ligands for nonopsonic phagocytosis by fibronectin-stimulated macrophages.

Kelly NM, Kluftinger JL, Pasloske BL, Paranchych W, Hancock RE.

Infect Immun. 1989 Dec;57(12):3841-5.

22.

The activity of the Pseudomonas aeruginosa pilin promoter is enhanced by an upstream regulatory site.

Pasloske BL, Drummond DS, Frost LS, Paranchych W.

Gene. 1989 Sep 1;81(1):25-34.

PMID:
2572513
23.
24.

Two unusual pilin sequences from different isolates of Pseudomonas aeruginosa.

Pasloske BL, Sastry PA, Finlay BB, Paranchych W.

J Bacteriol. 1988 Aug;170(8):3738-41.

25.
26.

The expression of Pseudomonas aeruginosa PAK pilin gene mutants in Escherichia coli.

Pasloske BL, Carpenter MR, Frost LS, Finlay BB, Paranchych W.

Mol Microbiol. 1988 Mar;2(2):185-95.

PMID:
3132584
27.

Serial isolates of Pseudomonas aeruginosa from a cystic fibrosis patient have identical pilin sequences.

Pasloske BL, Joffe AM, Sun Q, Volpel K, Paranchych W, Eftekhar F, Speert DP.

Infect Immun. 1988 Mar;56(3):665-72.

28.

Expression of the Pseudomonas aeruginosa PAK pilin gene in Escherichia coli.

Finlay BB, Pasloske BL, Paranchych W.

J Bacteriol. 1986 Feb;165(2):625-30.

29.

Comparative studies of the amino acid and nucleotide sequences of pilin derived from Pseudomonas aeruginosa PAK and PAO.

Sastry PA, Finlay BB, Pasloske BL, Paranchych W, Pearlstone JR, Smillie LB.

J Bacteriol. 1985 Nov;164(2):571-7.

30.

Cloning and sequencing of the Pseudomonas aeruginosa PAK pilin gene.

Pasloske BL, Finlay BB, Paranchych W.

FEBS Lett. 1985 Apr 22;183(2):408-12.

Supplemental Content

Loading ...
Support Center